You may be eligible if you have a body mass index (BMI) of 30 or higher, or if your BMI is 27 or higher and you have a weight-related health condition like type 2 diabetes, high blood pressure, or high cholesterol
doi:10.1016/S2213-8587(23)00188-5 Lingvay I, Catarig AM, Frias JP, et al
Based on individual patient response and tolerability, the dose may be further titrated in 2.5mg increments every four weeks, up to a maximum of 15mg per week
Capitalizing on over fifteen years of GLP-1 therapeutic applications, implementing these medications in addressing diabetes and obesity is progressively expanding
Stangenberg, S
Its receptor binding profile shows that it binds to GIP receptors with an affinity similar to the natural hormone but has a fivefold lower affinity for GLP-1 receptors